1. Home
  2. blog

Transcutaneous auricular VNS timed to movement boosts motor output without added autonomic effects

A Journal of Neuroscience study of 36 healthy adults finds 2‑second taVNS bursts timed to movement transiently increase corticospinal excitability and sensorimotor EEG without adding heart-rate or skin‑conductance effects; pupil dilation occurred regardless of movement state.

26 May 2026

Home EEG game PainWaive cut neuropathic pain in three of four participants in small UNSW trial

UNSW researchers report that PainWaive, an EEG-based brain-training game, reduced neuropathic pain in three of four people in a four-week home trial. The team used a $300 3D-printed headset and is recruiting larger trials in spinal pain and spinal cord injury.

26 May 2026

Sudoku increased theta and reduced beta in a single-subject consumer‑EEG test

Anastasiia Ku used a BrainBit Mindo headband in a five-session self-experiment (published May 2026) and found increased theta and decreased beta during Sudoku, with most channels returning near baseline after the task.

26 May 2026

The innovation that helped a ballerina with degenerative disease dance again

Dentsu Lab and NTT used a non-invasive EEG headset and machine learning to let Breanna Olson with ALS control a digital avatar and perform live in mixed reality in Amsterdam last December. The work, part of Project Humanity, remains a non-commercial prototype the teams are continuing to train with other users.

26 May 2026

Neurotechnology Industry Trends 2026: BCI, AI, Neuromodulation, Wearable EEG and Neural Data Privacy

For years, the neurotechnology industry was framed as a futuristic field: brain chips, thought-controlled computers, memory implants, mind-reading headsets and science-fiction promises about merging humans with machines. In 2026, the story is different

25 May 2026

MintNeuro signs multi‑year supply deal with Motif Neurotech and markets platform at global meetings

MintNeuro agreed a multi‑year supply deal with Motif Neurotech to provide neural sensing and stimulation chips for Motif's DOT implant, which has FDA clearance to begin a clinical trial in treatment‑resistant depression. The company also promoted its platform this week at the International Neuromodulation Society congress and Deep Tech Momentum 2026.

25 May 2026
1 2 ... 5 6 7 8 9 10 11 ... 26 27

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

Archives